Profiles for companies starting with 'o'
✉ Email this page to a colleague
Drugs and US Patents for o
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-006 | Nov 13, 2017 | DISCN | Yes | No | 9,444,503 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Otsuka | JYNARQUE | tolvaptan | TABLET;ORAL | 204441-002 | Apr 23, 2018 | AB2 | RX | Yes | No | 8,501,730 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Oxford Pharms | BACLOFEN | baclofen | TABLET;ORAL | 077088-001 | Oct 31, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Orbion Pharms | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 079229-005 | Nov 28, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Onesource Specialty | GANCICLOVIR SODIUM | ganciclovir sodium | INJECTABLE;INJECTION | 204560-001 | Nov 17, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Onyx Pharms Amgen | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-003 | Jun 7, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ohm Labs | IBUPROHM COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 074567-001 | Apr 17, 2001 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
